RT @Ophidian18: https://t.co/EtcyNQ1y74 doxorubicin is THE first line and most broadly effective treatment for Soft Tissue Sarcoma. There…
https://t.co/EtcyNQ1y74 doxorubicin is THE first line and most broadly effective treatment for Soft Tissue Sarcoma. There is no question and no debate. Preferentially Targeted delivery JUST to the cancer by #AVCT #AVA6000 will however revolutionise and im
RT @AnkitmanglaMD: Another case in point why OS should be abandoned as an endpoint in sarcoma world. https://t.co/VKTIggsEX4
RT @JTrentMDPhD: Survival of soft tissue #sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an…
RT @Kopper_Onc: Wow - retrospective review of 2045 patients from 12 EORTC sarcoma trials looking at Survival of soft tissue sarcoma patient…
RT @JTrentMDPhD: Survival of soft tissue #sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an…
RT @AnkitmanglaMD: Another case in point why OS should be abandoned as an endpoint in sarcoma world. https://t.co/VKTIggsEX4
A nice retrospective review of doxorubicin based regimen in advanced STS. Median PFS 4.2 months and mOS 15.7 months after 6 cycles!! #sarcoma
RT @Kopper_Onc: Wow - retrospective review of 2045 patients from 12 EORTC sarcoma trials looking at Survival of soft tissue sarcoma patient…
RT @JTrentMDPhD: Survival of soft tissue #sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an…
RT @Kopper_Onc: Wow - retrospective review of 2045 patients from 12 EORTC sarcoma trials looking at Survival of soft tissue sarcoma patient…
RT @JTrentMDPhD: Survival of soft tissue #sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an…
Another case in point why OS should be abandoned as an endpoint in sarcoma world.
Survival of soft tissue #sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an @EORTC -STBSG database study https://t.co/2lvd5dIBp4
RT @Kopper_Onc: Wow - retrospective review of 2045 patients from 12 EORTC sarcoma trials looking at Survival of soft tissue sarcoma patient…
RT @Kopper_Onc: Wow - retrospective review of 2045 patients from 12 EORTC sarcoma trials looking at Survival of soft tissue sarcoma patient…
Wow - retrospective review of 2045 patients from 12 EORTC sarcoma trials looking at Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study #sarcoma https://t.co/8